Prestige Consumer Healthcare Inc. (NYSE: PBH) Stock Competitors & Peer Comparison
See PBH's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PBH and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PBH | $50.93 | -1.45% | 2.4B | 11.43 | $4.42 | N/A |
| MCK | $863.20 | +1.11% | 98.2B | 20.55 | $40.82 | +0.39% |
| COR | $319.18 | +0.66% | 61.2B | 18.35 | $17.15 | +0.76% |
| CAH | $228.91 | -2.53% | 53.5B | 21.90 | $10.43 | +0.89% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $88.47 | -0.92% | 10.1B | 16.66 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| ACH | $1.24 | -6.44% | 99.9M | 1.92 | $0.68 | N/A |
| HX | $2.24 | -4.27% | 53.4M | -1.84 | -$1.22 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
PBH vs MCK Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, MCK has a market cap of 98.2B. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while MCK trades at $863.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas MCK's P/E ratio is 20.55. In terms of profitability, PBH's ROE is +0.09%, compared to MCK's ROE of -1.94%. Regarding short-term risk, PBH is less volatile compared to MCK. This indicates lower risk in terms of short-term price fluctuations for PBH.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
PBH vs COR Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, COR has a market cap of 61.2B. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while COR trades at $319.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas COR's P/E ratio is 18.35. In terms of profitability, PBH's ROE is +0.09%, compared to COR's ROE of +1.06%. Regarding short-term risk, PBH is less volatile compared to COR. This indicates lower risk in terms of short-term price fluctuations for PBH.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
PBH vs CAH Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, CAH has a market cap of 53.5B. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while CAH trades at $228.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas CAH's P/E ratio is 21.90. In terms of profitability, PBH's ROE is +0.09%, compared to CAH's ROE of -0.60%. Regarding short-term risk, PBH is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for PBH.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
PBH vs ABC Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas ABC's P/E ratio is 21.92. In terms of profitability, PBH's ROE is +0.09%, compared to ABC's ROE of +1.06%. Regarding short-term risk, PBH is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for PBH.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
PBH vs HSIC Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, HSIC has a market cap of 10.1B. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while HSIC trades at $88.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas HSIC's P/E ratio is 16.66. In terms of profitability, PBH's ROE is +0.09%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, PBH is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for PBH.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
PBH vs PDCO Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas PDCO's P/E ratio is 20.48. In terms of profitability, PBH's ROE is +0.09%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, PBH is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for PBH.Check PDCO's competition here
Owens & Minor, Inc. (NYSE: OMI)
PBH vs OMI Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas OMI's P/E ratio is -0.47. In terms of profitability, PBH's ROE is +0.09%, compared to OMI's ROE of +0.63%. Regarding short-term risk, PBH is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for PBH.Check OMI's competition here
Accendra Health, Inc. (NYSE: ACH)
PBH vs ACH Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, ACH has a market cap of 99.9M. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while ACH trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas ACH's P/E ratio is 1.92. In terms of profitability, PBH's ROE is +0.09%, compared to ACH's ROE of +0.63%. Regarding short-term risk, PBH is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for PBH.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
PBH vs HX Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas HX's P/E ratio is -1.84. In terms of profitability, PBH's ROE is +0.09%, compared to HX's ROE of -1.07%. Regarding short-term risk, PBH is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for PBH.Check HX's competition here
111, Inc. (NASDAQ: YI)
PBH vs YI Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, YI has a market cap of 29.8M. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while YI trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas YI's P/E ratio is -2.44. In terms of profitability, PBH's ROE is +0.09%, compared to YI's ROE of +0.14%. Regarding short-term risk, PBH is less volatile compared to YI. This indicates lower risk in terms of short-term price fluctuations for PBH.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
PBH vs WGRX Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas WGRX's P/E ratio is -0.33. In terms of profitability, PBH's ROE is +0.09%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, PBH is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for PBH.Check WGRX's competition here
ZeroStack Corp. (NASDAQ: ZSTK)
PBH vs ZSTK Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, ZSTK has a market cap of 6.2M. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while ZSTK trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas ZSTK's P/E ratio is -0.12. In terms of profitability, PBH's ROE is +0.09%, compared to ZSTK's ROE of -3.82%. Regarding short-term risk, PBH is less volatile compared to ZSTK. This indicates lower risk in terms of short-term price fluctuations for PBH.Check ZSTK's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
PBH vs MEDS Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, MEDS has a market cap of 3.8M. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while MEDS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas MEDS's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, PBH is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for PBH.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
PBH vs ZYXI Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, PBH's ROE is +0.09%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, PBH is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for PBH.Check ZYXI's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
PBH vs SNYR Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, SNYR has a market cap of 1.2M. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while SNYR trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas SNYR's P/E ratio is -0.08. In terms of profitability, PBH's ROE is +0.09%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, PBH is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for PBH.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
PBH vs RDGT Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, RDGT has a market cap of 724.3K. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while RDGT trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas RDGT's P/E ratio is -0.01. In terms of profitability, PBH's ROE is +0.09%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, PBH is less volatile compared to RDGT. This indicates lower risk in terms of short-term price fluctuations for PBH.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
PBH vs CVET Comparison August 2026
Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 2.4B. In comparison, CVET has a market cap of 0. Regarding current trading prices, PBH is priced at $50.93 on the NYSE, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 11.43, whereas CVET's P/E ratio is -69.97. In terms of profitability, PBH's ROE is +0.09%, compared to CVET's ROE of -0.06%. Regarding short-term risk, PBH is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for PBH.Check CVET's competition here